- SciVac Therapeutics changed its name to VBI Vaccines
- On May 6, 2016, each share of VBI Vaccines common stock was converted into the right to receive 0.520208 common shares of post-merger VBI Vaccines
- On May 9, 2016, the combined entity began trading on The NASDAQ Capital Market under the symbol "VBIV"
Additional InformationAdditional combined company information can be found at the VBI website:
- Website Home: http://www.vbivaccines.com/
- News and Insights: http://www.vbivaccines.com/wire/
- Investors: http://www.vbivaccines.com/investors/
VBI ContactPerri Maduri, Communications ExecutivePhone: (617) 830-3031 x124Email: email@example.comVBI Investor ContactNell BeattieDirector, Corporate Development and Investor RelationsPhone: (617) 830-3031 x128Email: firstname.lastname@example.org